Haemonetics Corp (HAE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 320,846 | 299,283 | 344,429 | 178,800 | 193,978 |
| Receivables | 211,949 | 213,534 | 201,485 | 206,562 | 211,611 |
| Inventories | 359,614 | 382,105 | 373,787 | 317,202 | 304,024 |
| TOTAL | $1,005,868 | $955,902 | $978,578 | $768,903 | $764,982 |
| Non-Current Assets | |||||
| PPE Net | 286,107 | 300,478 | 302,480 | 311,362 | 318,665 |
| Intangibles | 1,070,881 | 1,103,999 | 1,108,282 | 971,199 | 984,269 |
| Other Non-Current Assets | 168,414 | 164,845 | 151,637 | 144,127 | 132,512 |
| TOTAL | $1,525,402 | $1,569,322 | $1,562,399 | $1,426,688 | $1,435,446 |
| Total Assets | $2,531,270 | $2,525,224 | $2,540,977 | $2,195,591 | $2,200,428 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 62,990 | 69,242 | 76,929 | 73,358 | 56,845 |
| Accrued Expenses | 45,933 | 49,300 | 40,768 | 80,708 | 58,762 |
| Other current liabilities | 139,235 | 149,970 | 137,270 | 136,088 | 132,412 |
| TOTAL | $253,233 | $273,946 | $260,076 | $300,383 | $261,755 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,219,762 | 1,219,523 | 1,218,477 | 797,564 | 856,849 |
| Other Non-Current Liabilities | 89,964 | 90,011 | 92,263 | 75,041 | 76,259 |
| TOTAL | $1,371,177 | $1,372,427 | $1,375,533 | $935,249 | $995,354 |
| Total Liabilities | $1,624,410 | $1,646,373 | $1,635,609 | $1,235,632 | $1,257,109 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 50,237 | 50,224 | 51,178 | 50,841 | 50,786 |
| Common Shares | 502 | 504 | 512 | 508 | 508 |
| Retained earnings | 392,230 | 368,536 | 386,642 | 360,456 | 340,099 |
| Other shareholders' equity | -55,501 | -34,564 | -42,667 | -35,632 | -24,382 |
| TOTAL | $906,860 | $878,851 | $905,368 | $959,959 | $943,319 |
| Total Liabilities And Equity | $2,531,270 | $2,525,224 | $2,540,977 | $2,195,591 | $2,200,428 |